Progress And Pitfalls Ahead As UK Medtech Faces A Year Of Leaving The EU

As the UK enters the final week of its 47-year membership of the EU, UK medtech industry and commentators look ahead to the routes beyond Brexit for the UK, and a likely intense and often rocky 11 months of trade deal negotiations with EU and global partners. This article is part one of two.

Draughts

More from Regulation

More from Policy & Regulation